发明名称 Piperazine compounds as inhibitors of MMP or TNF
摘要 A compound of formula (I) wherein A is a sulfonyl or a carbonyl; R 1 is an optionally substituted aryl, an optionally substituted heterocyclic group, an optionally substituted lower alkyl or an optionally substituted lower alkenyl; R 2 is a hydrogen, an optionally substituted lower alkyl, an optionally substituted aryl or an optionally substituted heterocyclic group; R 3 is an optionally substituted lower alkyl, an optionally substituted lower alkoxy, an optionally substituted aryloxy, an optionally substitued lower alkenyl, an optionally substituted aryl, an optionally substituted heterocyclic group or an optionally substitued amino, R 4 is a hydrogen, an optionally substituted lower alkyl, an optionally substituted aryl or an optionally substituted heterocyclic group, R 5 is a hydrogen, an optionally substituted lower alkyl, an optionally substituted aryl or an optionally substituted heterocyclic group; and R 10 is a hydroxy or a protected hydroxy, and a pharmaceutically acceptable salt thereof. The compound of the present invention is useful as a medicament for prophylactic and therapeutic treatment of MMP- or TNF±-mediated diseases.
申请公布号 US2002128270(A1) 申请公布日期 2002.09.12
申请号 US20010982869 申请日期 2001.10.22
申请人 FUJISAWA PHARMACEUTICAL CO., LTD. 发明人 NEYA MASAHIRO;YAMAZAKI HITOSHI;KAYAKIRI NATSUKO;SATO KENTARO;OKU TERUO
分类号 A61K31/495;A61K31/496;A61P17/02;A61P17/06;A61P19/02;A61P43/00;C07D241/04;C07D405/12;C07D405/14;C07D407/12;C07D409/12;C07D409/14;C07D413/12;C07D413/14;C07D417/12;C07D417/14;(IPC1-7):A61K31/496;C0743/02 主分类号 A61K31/495
代理机构 代理人
主权项
地址